Control of cytokine gene expression using small RNA interference: Blockade of interleukin-10 and interferon-gamma gene expression in pig cells

Veterinary Immunology and Immunopathology

Volumn 117, Issue 1-2, 2007, Pages 86-94

  Sidahmed, A M E ^a   Wilkie, B N ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Antisense; Blood monunuclear cells; Cytokines; IFN ; IL 10; Oligodeoxynucleotides; Pig

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; BETA 2 MICROGLOBULIN; CYTOKINE; DNA; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GAMMA INTERFERON; INTERLEUKIN 10; RNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME IMMUNOASSAY; GENE EXPRESSION REGULATION; MONONUCLEAR CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SWINE;

ANIMALS; BETA 2-MICROGLOBULIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; INTERFERON TYPE II; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; OLIGONUCLEOTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA INTERFERENCE; RNA, SMALL INTERFERING; SPECIFIC PATHOGEN-FREE ORGANISMS; SWINE;

ESCHERICHIA COLI; SUIDAE;

EID: 34147125255     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2007.02.006     Document Type: Article

References (35)

1. Arima H., Sakamoto T., Aramaki Y., Ishidate K., and Tsuchiya S. Specific inhibition of nitric oxide production in macrophages by phosphorothioate antisense oligonucleotides. J. Pharm. Sci. 86 (1997) 1079-1084
2. Arima H., Takahashi M., Aramaki Y., Sakamoto T., and Tsuchiya S. Specific inhibition of interleukin-10 production in murine macrophage-like cells by phosphorothioate antisense oligonucleotides. Antisense Nucl. Acid Drug Dev. 8 4 (1998) 319-327
3. Arima H., Takahashi M., Aramaki Y., Sakamoto T., Yuda K., Akiyama K., Goto T., and Tsuchiya S. Design of potent phosphorothioate antisense oligonucleotides directed to human interleukin 10 gene product and their evaluation of antisense activity in U937cells. Pharm. Res. 16 8 (1999) 1163-1171
4. Boeve C.M., and De Ley M. Inhibition of human interferon-gamma expression by antisense oligodeoxynucleotides. J. Leukocyte Biol. 55 2 (1994) 169-174
5. Boeve C.M., and De Ley M. Modulation of human interferon-gamma biosynthesis by antisense oligodeoxynucleotides. Mol. Biotechnol. 14 2 (2000) 157-163
6. Buechler C., Ritter M., Orso E., Langmann T., Klucken J., and Schmitz G. Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and anti-inflammatory stimuli. J. Leukocyte Biol. 67 (2000) 97-103
7. Burgess T.L., Fisher E.F., Ross S.L., Bready J.V., Qian Y.X., Bayewitch L.A., Cohen A.M., Herrera C.J., Hu S.S., Kramer T.B., lott F.D., Martin F.H., Pierce G.F., Simonet L., and Farrell C.L. The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 4051-4055
8. Campbell J.M., Bacon T.A., and Wickstrom E. Oligodeoxynucleoside phosphorothioate stability in subcellular extracts, culture media, sera and cerebrospinal fluid. J. Biochem. Biophys. Methods 20 (1990) 259-267
9. Chiang M.Y., Chan H., Zounes M.A., Freier S.M., Lima W.F., and Bennett C.F. Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. J. Biol. Chem. 266 27 (1991) 18162-18171
10. Cohen J.S. Informational drugs: a new concept in pharmacology. Antisense Res. Dev. 1 (1991) 191-193
11. Crooke S.T. Phosphorothioate oligonucleotides. In: Crooke S.T. (Ed). Therapeutic Applications of Oligonucleotides (1995), R.G. Landes, Austin p. 79
12. Crooke S.T. Basic principles of antisense therapeutics. In: Agrawal S., and Crooke S.T. (Eds). Antisense Research and Application, Handbook of Experimental Pharmacology 131 (1998), Springer-Verlag 1-50
13. Cullen R.B. Enhancing and confirming the specificity of RNAi experiments. Nat. Methods 3 9 (2006 Sep) 677-681
14. Dias N., Dheur S., Nielsen P.E., Gryaznov S., Van Aerschot A., Herdewijn P., Helene C., and Saison-Behmoaras T.E. Antisense PNA tridecamers targeted to the coding region of Ha-ras mRNA arrest polypeptide chain elongation. J. Mol. Biol. 29 (1999) 403-416
15. Eder P.S., DeVine R.J., Dagle J.M., and Walder J.A. Substrate specificity and kinetics of degradation of antisense oligonucleotides by a 3′ exonuclease in plasma. Antisense Res. Dev. 1 (1991) 141-151
16. Goodchild J., Carroll III E., and Greenberg J.R. Inhibition of rabbit β-globin synthesis by complementary oligonucleotides: indentification of mRNA sites sensitive to inhibition. Arch. Biochem. Biophys. 263 (1988) 401-409
17. Hauber I., Wolf H.M., Samstag A., Pein B., Kreil T.R., Gulle H., Fischer M.B., and Eibl M.M. Inhibition of IL-10 protein synthesis induces major histocompatibility complex class II gene expression in class II-deficient patients. Cell. Immunol. 180 2 (1997) 95-103
18. Kurreck J. Antisense technologies. Improvement through novel chemical modifications. Eur. J. Biochem. 270 8 (2003) 1628-1644
19. Liu J., Chen I., Chua H., Du Q., and Kwang J. Inhibition of porcine circovirus type 2 replication in mice by RNA interference. Virology 347 (2006) 422-433
20. Maier J.A.M., Voulalas P., Roeder D., and Maciag T. Extention of the life-span of human endothelial cells by an interleukin-1α antisense oligomer. Science 249 (1990) 1570-1574
21. Masood R., Zhang Y., Bond M.W., Scadden D.T., Moudgil T., Law R.E., Kaplan M.H., Jung B., Espina B.M., Lunardi-Iskandar Y., Levine A.M., and Gill P.S. Interleukin-10 is an autocrine growth factor for acquired immunodeficiency syndrome-related B-cell lymphoma. Blood 85 12 (1995) 3423-3430
22. Monia B.P., Johnston J.F., Ecker D.J., Zounes M.A., Lima W.F., and Freier S.M. Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides. J. Biol. Chem. 267 (1992) 19954-19962
23. Natesampillai S., Fernando-Zampico M.E., Urrutial R., and Velduis J.D. A novel functional interaction between the Sp1-like protein KLF13 and SREBP-Sp1 activation complex underlies regulation of low density lipoprotein receptor promoter function. J. Biol. Chem. 281 (2006) 3040-3047
24. Peng B., Mehta N.H., Fernandes H., Chou C.C., and Raveche E. Growth inhibition of malignant CD5 + B (B-1) cells by antisense IL-10 oligonucleotide. Leukemia Res. 3 (1995) 159-167
25. Popescu F.D. Antisense-and RNA interference-based therapeutic strategies in allergy. J. Cell. Mol. Med. 9 4 (2005 Oct-Dec) 840-853
26. Reddy, J.N.R., 1998. Cytokines in pigs bred selectivley for high and low immune response. PhD Thesis, The University of Guelph (Chapter 4).
27. 2-microglobulin mRNA expression by reverse transcription polymerase chain reaction. J. Immunol. Methods 233 1/2 (2000) 8393
28. Rossi J., and Scherer L. Approaches for the sequence-specific knockdown of mRNA. Nat. Biotechnol. 21 12 (2003 Dec) 1457-1465
29. Schwab G., Siegall C.B., Aarden L.A., Neckers L.M., and Nordan R.P. Characterization of an interleukin-6-mediated autocrine growth loop in the human mutiple myeloma cell line, U266. Blood 77 (1991) 587-593
30. Stein C.A. Does antisense exist?. Nat. Med. 1 (1995) 1119-1121
31. Stein C.A., and Krieg A.M. Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides. Antisense Res. Dev. 4 2 (1994) 67-69
32. Verfaillie T., Cox E., To L.T., Vanrompay D., Bouchaut H., Buys N., and Goddeeris B.M. Comparative analysis of porcine cytokine production by mRNA and protein detection. Vet. Immunol. Immunopathol. 81 (2001) 97-112
33. Wittwr C.T., Ririe K.M., Andrew R.V., David D.A., Gundry R.A., and Balis U.J. Continuous fluorescence monitoring of rapid cycle DNA amplification. Biotechniques 22 (1997) 176-181
34. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., and Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249 (1990) 1431-1433
35. Wyatt J.R., Vickers T.A., Roberson J.L., Buckheit Jr. R.W., Klimkait T., DeBaets E., Davis P.W., Rayner B., Imbach J.L., and Ecker D.J. Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion. Proc. Natl. Acad. Sci. U.S.A. 91 4 (1994) 1356-1360